A.R.C. K.E.M. Hospital Mumbai,Maharashtra,India Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00753064
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

anti-scorpion venom serum (1 trial)

prazosin (minipress) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Poisoning (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2